← Open Payments lookup

KERI DRURY: Open Payments

NPI 1972762920 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$498 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $260 · 2025 $498

Food & beverage: $498
CompanyPaymentsAmount
Janssen Biotech, Inc.4$119
UCB, Inc.2$78
Amgen Inc.3$57
ABBVIE INC.2$47
AstraZeneca Pharmaceuticals LP2$44
Octapharma USA, Inc.1$40
GENZYME CORPORATION1$32
Organon LLC1$31
Alexion Pharmaceuticals, Inc.1$28
GlaxoSmithKline, LLC.1$23

Products named: TREMFYA, Bimzelx, SAPHNELO, OCTAGAM IMMUNE GLOBULIN (HUMAN), OTEZLA, KEVZARA, HADLIMA, STRENSIQ.

Industry payments across WA — which companies pay providers there.